Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Ruxolitinib (S enantiomer)

Selected Variant

HY-50856A-01

Size: 5 mg

Ruxolitinib (S enantiomer) (S-Ruxolitinib) is the S-enantiomer of Ruxolitinib. Ruxolitinib (S enantiomer) is an orally active, potent JAK inhibitor[1][2].

Product Specifications

CAS Number

941685-37-6

Product Name Alternative

S-Ruxolitinib; S-INCB18424

UNSPSC

12352005

Target

JAK

Type

Reference compound

Related Pathways

Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/ruxolitinib-s-enantiomer.html

Concentration

10mM

Purity

99.94

Solubility

1M HCl : 50 mg/mL (ultrasonic; adjust pH to 1 with HCl) |DMSO : ≥ 100 mg/mL

Smiles

N#CC[C@@H](C1CCCC1)N2N=CC(C3=NC=NC4=C3C=CN4)=C2

Molecular Formula

C17H18N6

Molecular Weight

306.37

References & Citations

[1]Hye Kyung Lee, et al. JAK inhibitors dampen activation of interferon-stimulated transcription of ACE2 isoforms in human airway epithelial cells. Commun Biol. 2021 Jun 2;4 (1) :654.|[2]Lorena Arranz, et al. Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms. Nature. 2014 Aug 7;512 (7512) :78-81.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Launched

Isoform

JAK

Available Sizes

Price

Sign In for Pricing

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog